Answer
Yes, increased sensitivity to sunlight has been reported with Alecensa (alectinib hydrochloride), and patients should avoid prolonged sun exposure during treatment and for at least seven days after stopping.
Sources for this answer
- Alecensa 150 mg Hard CapsulesRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 17Document updated
Sources checked